Minimed Group Inc (MMED)

$11.89 +0.73 (6.54%)
Market Cap 3.13B
Revenue (ttm) 2.72B
Net Income (ttm) -250.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 20.88
Profit Margin -9.21%
Debt to Equity Ratio 0.00
Volume 1,054,900
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 280.82M
Stochastic %K 48%
Beta N/A
Analysts Strong Sell
Price Target $22.40

Company Profile

MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform i...

Industry: Health Information Services
Sector: Healthcare
Phone: (763) 514-4000
Address:
18000 Devonshire Street, Northridge, United States
cberryman
cberryman May. 7 at 11:37 AM
$TNDM The analysts that are coming out ahead of earnings with ‘Strong Buy’ recommendation; I wonder how many endocrinologists they’ve spoken with to research their recommendation. Endos are seriously scrambling to offload Tandem users onto other systems due to Trusteel inventory availability and lack of guidance for resolution. Many long-term Tandem customers cannot switch to Teflon based cannulas due to reactions or scarring from years of use. $MMED will be the primary beneficiary of the off-cycle pump and supply switching wave.
2 · Reply
deepthinker
deepthinker May. 5 at 7:42 PM
$MMED So, you’re telling me that $MDT can buy back the shares it just sold at $20 for under $12? One heck of a trade.
0 · Reply
deepthinker
deepthinker May. 4 at 10:47 PM
$MMED CEO makes $10 million. So, great work.🤔
0 · Reply
deepthinker
deepthinker Apr. 5 at 2:58 PM
$MMED The reason this was spun-off is because no one would buy it outright. The temptation now is to dump more bad stuff into MMED.
1 · Reply
stockstradumbass
stockstradumbass Apr. 2 at 4:34 PM
$MMED May have found bottom here. Planning to start position soon.
0 · Reply
Par4real
Par4real Apr. 2 at 3:30 AM
$MMED from $20 to $14 in a month. 🥶
1 · Reply
deepthinker
deepthinker Mar. 13 at 4:09 PM
$MMED I guess this IPO was priced too high.🤣🤣🤣
0 · Reply
vermigli
vermigli Mar. 11 at 2:49 PM
$MMED is MiniMed so why does StockTwits show the company name as “Mind Med”?
0 · Reply
smartkarma
smartkarma Mar. 10 at 3:15 AM
$MMED | MiniMed (MMED US): Low Passive Fund Flows Due to Low Float "​MiniMed (MMED US) went public on 6 March on Nasdaq and has a $5.2bn market cap, but faces exclusion from major US and Global indices due to low float cap and free float." - Dimitris Ioannidis (ORTEX) Read more: https://www.smartkarma.com/insights/minimed-mmed-us-low-passive-fund-flows-due-to-low-float
0 · Reply
theflynews
theflynews Mar. 9 at 2:31 PM
Opening Day: Honeywell readies spinoff as MiniMed makes Nasdaq debut - $MMED - https://thefly.com/MMED
0 · Reply
Latest News on MMED
MiniMed initiated with a Buy at Benchmark

2026-05-12T09:38:09.000Z - 1 day ago

MiniMed initiated with a Buy at Benchmark

MiniMed initiated with a Buy at Benchmark

2026-05-11T20:50:33.000Z - 1 day ago

MiniMed initiated with a Buy at Benchmark

MiniMed 780G system software licensed by Health Canada

2026-04-28T13:55:33.000Z - 14 days ago

MiniMed 780G system software licensed by Health Canada

MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System

Apr 28, 2026, 9:05 AM EDT - 14 days ago

MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System

MiniMed to announce financial results for its fourth quarter and full fiscal year 2026

Apr 13, 2026, 4:01 PM EDT - 4 weeks ago

MiniMed to announce financial results for its fourth quarter and full fiscal year 2026

MiniMed initiated with a Buy at Deutsche Bank

2026-03-31T14:22:19.000Z - 6 weeks ago

MiniMed initiated with a Buy at Deutsche Bank

Deutsche starts MiniMed with Buy on attractive entry point

2026-03-31T13:43:49.000Z - 6 weeks ago

Deutsche starts MiniMed with Buy on attractive entry point

MiniMed initiated with a Buy at Goldman Sachs

2026-03-31T10:55:50.000Z - 6 weeks ago

MiniMed initiated with a Buy at Goldman Sachs

MiniMed initiated with an Outperform at William Blair

2026-03-31T10:30:10.000Z - 6 weeks ago

MiniMed initiated with an Outperform at William Blair

MiniMed initiated with an Overweight at Barclays

2026-03-31T10:29:45.000Z - 6 weeks ago

MiniMed initiated with an Overweight at Barclays

MiniMed initiated with a Buy at BofA

2026-03-31T10:19:44.000Z - 6 weeks ago

MiniMed initiated with a Buy at BofA

MDT

MiniMed initiated with an Overweight at Wells Fargo

2026-03-31T10:15:11.000Z - 6 weeks ago

MiniMed initiated with an Overweight at Wells Fargo

MiniMed initiated with a Buy at Citi

2026-03-31T10:06:10.000Z - 6 weeks ago

MiniMed initiated with a Buy at Citi

MiniMed initiated with an Outperform at Evercore ISI

2026-03-31T10:05:12.000Z - 6 weeks ago

MiniMed initiated with an Outperform at Evercore ISI

MiniMed initiated with a Buy at BTIG

2026-03-31T09:55:43.000Z - 6 weeks ago

MiniMed initiated with a Buy at BTIG

MiniMed initiated with an Overweight at Morgan Stanley

2026-03-31T09:30:43.000Z - 6 weeks ago

MiniMed initiated with an Overweight at Morgan Stanley

MiniMed initiated with an Outperform at Mizuho

2026-03-31T09:25:11.000Z - 6 weeks ago

MiniMed initiated with an Outperform at Mizuho

MiniMed Announces FDA Clearance of MiniMed Flex™, the Company's Smallest Insulin Pump Featuring Its First Smartphone-Controlled Design

Mar 18, 2026, 9:06 AM EDT - 7 weeks ago

MiniMed Announces FDA Clearance of MiniMed Flex™, the Company's Smallest Insulin Pump Featuring Its First Smartphone-Controlled Design

MiniMed announces closing of Initial Public Offering

Mar 9, 2026, 4:59 PM EDT - 2 months ago

MiniMed announces closing of Initial Public Offering

Medtronic's diabetes unit MiniMed valued at $5.3 billion as shares fall in Nasdaq debut

Mar 6, 2026, 12:16 PM EST - 2 months ago

Medtronic's diabetes unit MiniMed valued at $5.3 billion as shares fall in Nasdaq debut

MDT

MiniMed to begin trading on Nasdaq Global Select Market

Mar 6, 2026, 9:00 AM EST - 2 months ago

MiniMed to begin trading on Nasdaq Global Select Market

MDT

MiniMed begins trading on Nasdaq Global Select Market

Mar 6, 2026, 9:00 AM EST - 2 months ago

MiniMed begins trading on Nasdaq Global Select Market

Medtronic's diabetes unit MiniMed raises $560 million in US IPO

Mar 5, 2026, 7:44 PM EST - 2 months ago

Medtronic's diabetes unit MiniMed raises $560 million in US IPO

MDT

Medtronic's MiniMed aims to raise $784 million in US IPO

Feb 24, 2026, 6:40 AM EST - 2 months ago

Medtronic's MiniMed aims to raise $784 million in US IPO

MDT

Study showed MiniMed™ 780G system achieved ADA-recommended time-in-range goals even on days users forgot to bolus

Jan 7, 2026, 9:05 AM EST - 4 months ago

Study showed MiniMed™ 780G system achieved ADA-recommended time-in-range goals even on days users forgot to bolus

Medtronic Spin-Off MiniMed Files for IPO

Dec 19, 2025, 4:53 PM EST - 5 months ago

Medtronic Spin-Off MiniMed Files for IPO

MDT

Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed

Dec 19, 2025, 4:20 PM EST - 5 months ago

Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed

MDT

Medtronic's MiniMed files for US IPO

Dec 19, 2025, 4:16 PM EST - 5 months ago

Medtronic's MiniMed files for US IPO

MDT

MiniMed Group IPO Registration Document (S-1)

Dec 19, 2025, 4:03 PM EST - 5 months ago

MiniMed Group IPO Registration Document (S-1)

cberryman
cberryman May. 7 at 11:37 AM
$TNDM The analysts that are coming out ahead of earnings with ‘Strong Buy’ recommendation; I wonder how many endocrinologists they’ve spoken with to research their recommendation. Endos are seriously scrambling to offload Tandem users onto other systems due to Trusteel inventory availability and lack of guidance for resolution. Many long-term Tandem customers cannot switch to Teflon based cannulas due to reactions or scarring from years of use. $MMED will be the primary beneficiary of the off-cycle pump and supply switching wave.
2 · Reply
deepthinker
deepthinker May. 5 at 7:42 PM
$MMED So, you’re telling me that $MDT can buy back the shares it just sold at $20 for under $12? One heck of a trade.
0 · Reply
deepthinker
deepthinker May. 4 at 10:47 PM
$MMED CEO makes $10 million. So, great work.🤔
0 · Reply
deepthinker
deepthinker Apr. 5 at 2:58 PM
$MMED The reason this was spun-off is because no one would buy it outright. The temptation now is to dump more bad stuff into MMED.
1 · Reply
stockstradumbass
stockstradumbass Apr. 2 at 4:34 PM
$MMED May have found bottom here. Planning to start position soon.
0 · Reply
Par4real
Par4real Apr. 2 at 3:30 AM
$MMED from $20 to $14 in a month. 🥶
1 · Reply
deepthinker
deepthinker Mar. 13 at 4:09 PM
$MMED I guess this IPO was priced too high.🤣🤣🤣
0 · Reply
vermigli
vermigli Mar. 11 at 2:49 PM
$MMED is MiniMed so why does StockTwits show the company name as “Mind Med”?
0 · Reply
smartkarma
smartkarma Mar. 10 at 3:15 AM
$MMED | MiniMed (MMED US): Low Passive Fund Flows Due to Low Float "​MiniMed (MMED US) went public on 6 March on Nasdaq and has a $5.2bn market cap, but faces exclusion from major US and Global indices due to low float cap and free float." - Dimitris Ioannidis (ORTEX) Read more: https://www.smartkarma.com/insights/minimed-mmed-us-low-passive-fund-flows-due-to-low-float
0 · Reply
theflynews
theflynews Mar. 9 at 2:31 PM
Opening Day: Honeywell readies spinoff as MiniMed makes Nasdaq debut - $MMED - https://thefly.com/MMED
0 · Reply
smartkarma
smartkarma Mar. 9 at 1:23 AM
$MMED | MiniMed Debuts on Nasdaq as IPO Prophet Signals Align With Weak First-Day Trading "MiniMed Group, Inc. (MMED) , a diabetes technology company with approximately $2.3 billion in fiscal 2024 revenue , began trading on the Nasdaq on..." - IPO Prophet (IPO Prophet) Read more: https://www.smartkarma.com/insights/minimed-debuts-on-nasdaq-as-ipo-prophet-signals-align-with-weak-first-day-trading
0 · Reply
IPOtweet
IPOtweet Mar. 6 at 10:40 PM
US IPO Weekly Recap: Diabetes medtech MiniMed slides 8% in a quiet week for IPOs $MMED $RVI $GLEDU $KCAC.U $IPO #IPO https://zpr.io/nxGRHi
0 · Reply
smartkarma
smartkarma Mar. 6 at 9:53 PM
$MMED | MiniMed Group, Inc. (MMED): Medtronic Spinoff Falls on First Day Despite Deep IPO Discount "​MiniMed's IPO priced at $20, below range, reflecting weak demand and cautious investor sentiment, but reduced valuation may stabilize stock as investors reassess long-term fundamentals." - IPO Boutique (IPO Boutique) Read more: https://www.smartkarma.com/insights/minimed-group-inc-mmed-medtronic-spinoff-falls-on-first-day-despite-deep-ipo-discount
0 · Reply
quotient
quotient Mar. 6 at 9:19 PM
$GENB $MMED Now MMED too..
0 · Reply
Fullport0dtexx
Fullport0dtexx Mar. 6 at 5:18 PM
$MMED opening a short! Scam stock will be delisted
0 · Reply
notreload_ai
notreload_ai Mar. 6 at 5:14 PM
$MMED MiniMed opens at $19.05, IPO priced at $20.
0 · Reply
InItToWinIt100
InItToWinIt100 Mar. 6 at 5:10 PM
$MMED Everybody ready?
0 · Reply
prismmarketview
prismmarketview Mar. 6 at 4:37 PM
MiniMed Group (NASDAQ: $MMED), Medtronic’s diabetes spin‑off, has priced its IPO at $20 per share for 28 million shares to raise $560M, and will start trading on the Nasdaq Global Select Market tomorrow under ticker MMED, with Medtronic retaining roughly 90% ownership post‑offering. https://prismmarketview.com/minimed-prices-initial-public-offering-as-medtronic-diabetes-unit-prepares-to-trade-independently/
0 · Reply
IPOtweet
IPOtweet Mar. 6 at 3:44 AM
Medtronic diabetes business carve-out MiniMed prices IPO at $20, below the range $MMED $IPO #IPO https://zpr.io/qUj3cbLgHvsh
0 · Reply
smartkarma
smartkarma Mar. 3 at 4:07 PM
$MMED | MiniMed Group, Inc. (MMED): Spin-Off IPO Story of Scale, Recurring Revenue, and Royalty Questions "​MiniMed seeks high valuation in IPO with Medtronic retaining majority ownership, offering comprehensive Smart Dosing ecosystem but facing challenges with reimbursement." - IPO Boutique (IPO Boutique) Read more: https://www.smartkarma.com/insights/minimed-group-inc-mmed-spin-off-ipo-story-of-scale-recurring-revenue-and-royalty-questions
0 · Reply
IPOtweet
IPOtweet Feb. 28 at 12:46 AM
US IPO Week Ahead: Medtronic carve-out MiniMed to kick-off March calendar $MMED $CAST $RVI $IPO #IPO https://zpr.io/Tgtw6bzXccbp
0 · Reply